The skipping of exon 2 that encodes these motifs or exons 2+3 in NFE2L2 gene was observed in lung and head and neck cancers, resulting in Nrf2 forms resistant to Keap1-mediated degradation [15]. Here, NFE2L2 is linked to head and neck cancer.